Showing results (401-410 of 418) with videos related to
Sort By:
Pageof 42
ACS Infectious Diseases|April 30, 2021
Repositioning and Characterization of 1-(Pyridin-4-yl)pyrrolidin-2-one Derivatives as Plasmodium Cytoplasmic Prolyl-tRNA Synthetase InhibitorsMasanori Okaniwa, Akira Shibata, Atsuko Ochida, et al.Journal of Medicinal Chemistry|February 5, 2019
3,3'-Disubstituted 5,5'-Bi(1,2,4-triazine) Derivatives with Potent in Vitro and in Vivo Antimalarial ActivityLian Xue, Da-Hua Shi, Jitendra R Harjani, et al.Biorxiv : the Preprint Server for Biology|January 7, 2025
A new class of penicillin-binding protein inhibitors to address drug-resistant Neisseria gonorrhoeaeTsuyoshi Uehara, Allison L Zulli, Brittany Miller, et al.Nature Communications|November 26, 2014
Pyrazoleamide compounds are potent antimalarials that target Na+ homeostasis in intraerythrocytic Plasmodium falciparumAkhil B Vaidya, Joanne M Morrisey, Zhongsheng Zhang, et al.Journal of Medicinal Chemistry|June 18, 2016
Trisubstituted Pyrimidines as Efficacious and Fast-Acting AntimalarialsNeil R Norcross, Beatriz Baragaña, Caroline Wilson, et al.Nature Microbiology|April 8, 2026
A penicillin-binding protein inhibitor series to target drug-resistant Neisseria gonorrhoeaeTsuyoshi Uehara, Allison L Zulli, Brittany Miller, et al.Journal of Medicinal Chemistry|July 10, 2014
N-aryl-2-aminobenzimidazoles: novel, efficacious, antimalarial lead compoundsSreekanth Ramachandran, Shahul Hameed P, Abhishek Srivastava, et al.Science Translational Medicine|December 13, 2023
DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1Stéphanie Braillard, Martine Keenan, Karen J Breese, et al.Nature|May 21, 2010
Chemical genetics of Plasmodium falciparumW Armand Guiguemde, Anang A Shelat, David Bouck, et al.Journal of Medicinal Chemistry|June 11, 2014
Aminoazabenzimidazoles, a novel class of orally active antimalarial agentsShahul Hameed P, Murugan Chinnapattu, Gajanan Shanbag, et al.Pageof 42